NITISINONE | NITISINONE | ATC A16AX04
METABOLISM HEREDITARY TYROSINEMIA TYPE 1 INHIBITOR OF 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE TREATMENT OF HEREDITARY TYROSINEMIA TYPE 1 (HT-1) | ORAL | Tmax 3 HOUR F 90 PERCENT Cl 0.26 LITER / HOUR (65 KILOGRAM) HT 54 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE | 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE INHIBITOR CHEMBL1861 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE P32754 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE HOMO SAPIENS ENZYME REDUCTASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |